Market Closed -
Other stock markets
|
Pre-market 09:29:01 am | |||
67.54 USD | -0.01% | 67.52 | -0.04% |
May. 16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
May. 16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
Business Summary
Number of employees: 797
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sacral Neuromodulation
79.6
%
| 222 | 81.1 % | 292 | 79.6 % | +31.45% |
Bulkamid
20.4
%
| 52 | 18.9 % | 75 | 20.4 % | +44.21% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
93.9
%
| 257 | 93.9 % | 344 | 93.9 % | +33.79% |
International
6.1
%
| 17 | 6.1 % | 22 | 6.1 % | +35.01% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 51 | 12-12-31 | |
Raymond Cohen
FOU | Founder | 65 | 13-09-30 |
Kari Keese
DFI | Director of Finance/CFO | 39 | 13-12-31 |
Rinda Sama
COO | Chief Operating Officer | 45 | 18-07-31 |
Karen Noblett
CTO | Chief Tech/Sci/R&D Officer | 61 | 17-09-30 |
Neil Bhalodkar
IRC | Investor Relations Contact | - | - |
Jennifer Riad
PRN | Corporate Officer/Principal | - | - |
Joe Manor
HRO | Human Resources Officer | - | - |
John Woock
SAM | Sales & Marketing | 41 | 14-05-31 |
Prabodh Mathur
PRN | Corporate Officer/Principal | 64 | 14-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Carrel
CHM | Chairman | 53 | 19-02-26 |
Nancy Snyderman
BRD | Director/Board Member | 72 | 19-04-07 |
Raymond Cohen
FOU | Founder | 65 | 13-09-30 |
Robert McNamara
BRD | Director/Board Member | 67 | 18-01-31 |
Jane Kiernan
BRD | Director/Board Member | 63 | 19-04-07 |
David Demski
BRD | Director/Board Member | 66 | 20-12-31 |
Esteban López
BRD | Director/Board Member | 51 | 21-07-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 51,018,478 | 50,472,767 ( 98.93 %) | 0 | 98.93 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.53% | 3.45B | |
+10.11% | 126B | |
-6.17% | 11.33B | |
+6.07% | 9.27B | |
+37.46% | 5.5B | |
-23.66% | 4.61B | |
-8.69% | 2.81B | |
-10.91% | 2.09B | |
-6.38% | 2.08B | |
-23.21% | 1.78B |
- Stock Market
- Equities
- AXNX Stock
- Company Axonics, Inc.